Eyepoint Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$966
$5,333
$24,453
$11,588
Gross Profit
245
5,168
23,648
10,772
EBITDA
-59,156
-61,689
-48,340
-40,828
EBIT
-59,732
-62,227
-48,837
-41,295
Net Income
-59,732
-59,426
-45,195
-41,399
Net Change In Cash
966
5,333
24,453
11,588
Free Cash Flow
-60,152
-63,809
-53,396
-36,233
Cash
74,577
71,143
85,158
99,704
Basic Shares
70,168
69,926
69,767
64,556

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$43,273
$46,018
$41,404
$36,939
Gross Profit
39,561
41,386
33,078
28,762
EBITDA
-129,226
-69,001
-96,619
-50,148
EBIT
-130,766
-69,465
-99,065
-52,919
Net Income
-130,870
-70,795
-102,254
-58,417
Net Change In Cash
43,273
46,018
41,404
36,939
Cost of Revenue
-82,960
133,684
Free Cash Flow
-130,278
-1,608
-67,155
-50,253
Cash
99,704
281,263
95,633
178,593
Basic Shares
56,298
38,904
37,317
28,758

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.85
2025-06-30
-$0.85
2025-03-31
-$0.65